Global OTC Anti-Infective Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global OTC Anti-Infective Products market size was valued at US$ 14210 million in 2024 and is forecast to a readjusted size of USD 17820 million by 2031 with a CAGR of 3.3% during review period.

Anti-infectives are medicines that work to prevent or treat infections.

Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.

Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.

This report is a detailed and comprehensive analysis for global OTC Anti-Infective Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global OTC Anti-Infective Products market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global OTC Anti-Infective Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global OTC Anti-Infective Products market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2020-2031

Global OTC Anti-Infective Products market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for OTC Anti-Infective Products

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global OTC Anti-Infective Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

OTC Anti-Infective Products market is split by Type and by Sales Channel. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others

Market segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Major players covered
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales quantity, revenue, and global market share of OTC Anti-Infective Products from 2020 to 2025.

Chapter 3, the OTC Anti-Infective Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Sales Channel, with sales market share and growth rate by Type, by Sales Channel, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and OTC Anti-Infective Products market forecast, by regions, by Type, and by Sales Channel, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of OTC Anti-Infective Products.

Chapter 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion.